Hemogenyx Pharmaceuticals plc (LSE: HEMO)*: £2.5m secured to continue its Phase I trials.One Health Group plc (AIM: OHGR): FY2026 Trading update
10 Feb 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
- Published:
10 Feb 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
3 -
Hemogenyx Pharmaceuticals plc (LSE: HEMO)*: £2.5m secured to continue its Phase I trials.One Health Group plc (AIM: OHGR): FY2026 Trading update